Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
424.00
-11.62 (-2.67%)
Mar 3, 2026, 10:47 AM EST - Market open
Madrigal Pharmaceuticals Market Cap
Madrigal Pharmaceuticals has a market cap or net worth of $9.73 billion as of March 3, 2026. Its market cap has increased by 26.80% in one year.
Market Cap
9.73B
Enterprise Value
9.01B
1-Year Change
26.80%
Ranking
Category
Stock Price
$424.00
Market Cap Chart
Since February 6, 2007, Madrigal Pharmaceuticals's market cap has increased from $297.50M to $9.73B, an increase of 3,169.43%. That is a compound annual growth rate of 20.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 9.99B | -24.44% |
| Dec 31, 2025 | 13.23B | 96.52% |
| Dec 31, 2024 | 6.73B | 47.33% |
| Dec 29, 2023 | 4.57B | -7.98% |
| Dec 30, 2022 | 4.96B | 242.65% |
| Dec 31, 2021 | 1.45B | -15.74% |
| Dec 31, 2020 | 1.72B | 22.31% |
| Dec 31, 2019 | 1.41B | -18.98% |
| Dec 31, 2018 | 1.74B | 51.27% |
| Dec 29, 2017 | 1.15B | 565.31% |
| Dec 30, 2016 | 172.40M | 255.46% |
| Dec 31, 2015 | 48.50M | -83.19% |
| Dec 31, 2014 | 288.60M | -20.30% |
| Dec 31, 2013 | 362.10M | -35.14% |
| Dec 31, 2012 | 558.30M | 141.48% |
| Dec 30, 2011 | 231.20M | -6.85% |
| Dec 31, 2010 | 248.20M | 44.39% |
| Dec 31, 2009 | 171.90M | -17.20% |
| Dec 31, 2008 | 207.60M | -8.55% |
| Dec 31, 2007 | 227.00M | -23.70% |
| Feb 6, 2007 | 297.50M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jazz Pharmaceuticals | 11.72B |
| BioMarin Pharmaceutical | 11.49B |
| ImmunityBio | 10.73B |
| Exelixis | 10.66B |
| Praxis Precision Medicines | 9.21B |
| ABIVAX Société Anonyme | 9.05B |
| Bio-Techne | 9.05B |
| Arrowhead Pharmaceuticals | 9.01B |